These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 3014253)
1. Neuro-endocrine aspects of the dexamethasone suppression test in psychiatry. Lamberts SW Life Sci; 1986 Jul; 39(2):91-5. PubMed ID: 3014253 [No Abstract] [Full Text] [Related]
2. [Clinical significance of the diagnostic use and assay of corticotropin-releasing hormone in the physiopathologic state of the hypothalamo-pituitary-adrenal axis]. Nishikawa T; Yoshida A; Mikami K; Tamura Y; Yoshida S Nihon Rinsho; 1990 Feb; 48 Suppl():182-4. PubMed ID: 2162415 [No Abstract] [Full Text] [Related]
3. Neuroendocrine disturbances and the diagnosis and aetiology of endogenous depression. Carroll BJ; Greden JF; Feinberg M Lancet; 1980 Feb; 1(8163):321-2. PubMed ID: 6101783 [No Abstract] [Full Text] [Related]
4. Are we in danger from an epidemic of Cushing's syndrome? Nature knows its course. Weaver JU Clin Endocrinol (Oxf); 2001 Dec; 55(6):719-21. PubMed ID: 11895210 [No Abstract] [Full Text] [Related]
9. [Hypothalamo-pituitary-adrenal cortex system and the glucocorticoid kinetics in Cushing's syndrome treated with chlodithane and large doses of reserpine]. Slavnov VN; Luchitskiĭ EV; Komissarenko IV; Markov VV; Cheban AK Ter Arkh; 1980; 52(7):124-8. PubMed ID: 6105729 [No Abstract] [Full Text] [Related]
10. Dysregulation of the hypothalamo-pituitary-adrenal axis and duration of diabetes. Roy M; Collier B; Roy A J Diabet Complications; 1991; 5(4):218-20. PubMed ID: 1663954 [TBL] [Abstract][Full Text] [Related]
11. [Contributions of cortisol suppression tests to understanding of psychiatric disorders: a narrative review of literature]. Tajima-Pozo K; Montes-Montero A; Güemes I; González-Vives S; Díaz-Marsá M; Carrasco JL Endocrinol Nutr; 2013; 60(7):396-403. PubMed ID: 23623464 [TBL] [Abstract][Full Text] [Related]
13. [Dexamethasone suppression test (DST): clinical use in psychiatry]. Morrissette L; Boucher H Union Med Can; 1986 Jan; 115(1):58-63. PubMed ID: 3952894 [No Abstract] [Full Text] [Related]
14. The hypothalamic-pituitary-adrenal axis in depression. Meltzer HY; Lowy MT; Koenig JI Adv Biochem Psychopharmacol; 1987; 43():165-82. PubMed ID: 3035885 [No Abstract] [Full Text] [Related]
15. Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer. Jehn CF; Kühnhardt D; Bartholomae A; Pfeiffer S; Schmid P; Possinger K; Flath BC; Lüftner D Integr Cancer Ther; 2010 Sep; 9(3):270-5. PubMed ID: 20702499 [TBL] [Abstract][Full Text] [Related]
16. Rate-sensitive inhibition of ACTH release in depression. Carr DB; Wool C; Lydiard RB; Fisher J; Gelenberg A; Klerman G Am J Psychiatry; 1984 Apr; 141(4):590-2. PubMed ID: 6322599 [TBL] [Abstract][Full Text] [Related]
17. Dexamethasone suppression test in geriatric depression. Alexopoulos GS; Young RC; Kocsis JH; Brockner N; Butler TA; Stokes PE Biol Psychiatry; 1984 Nov; 19(11):1567-71. PubMed ID: 6518207 [No Abstract] [Full Text] [Related]
18. Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression. Pfennig A; Kunzel HE; Kern N; Ising M; Majer M; Fuchs B; Ernst G; Holsboer F; Binder EB Biol Psychiatry; 2005 Feb; 57(4):336-42. PubMed ID: 15705348 [TBL] [Abstract][Full Text] [Related]
19. [Preliminary study of the dexamethasone suppression test in endogenous depression]. Omori T; Denda K; Koyama T; Matsubara S; Yasuda M Seishin Shinkeigaku Zasshi; 1983; 85(11):816-9. PubMed ID: 6677917 [No Abstract] [Full Text] [Related]